Шайдаков Евгений  Владимирович - доктор медицинских наук,
заместитель директора НИИнститута
Экспериментальной медицины СЗО РАМН
руководитель клиники института,
профессор кафедры ХУВ-1 ВМА
 XVI Европейский Венозный Форум 2015
 
                      Новости и блог          Биография          Библиография          Запись на приём          Публикации          Контакты      
 ФГБНУ «Институт экспериментальной медицины»  Санкт-Петербургская Ассоциация Флебологов (Saint-Petersburg Society of Phlebology, SPSP)  10-й Санкт-Петербургский Венозный Форум (Рождественские встречи) 30 ноября - 10 декабря 2017

16th EVF ANNUAL SCIENTIFIC MEETING: PROVISIONAL SCIENTIFIC PROGRAMME

30 июня 2015, 13:30:00
    

16th EVF ANNUAL SCIENTIFIC MEETING - 2-4 July 2015, St Petersburg, Russia

PROVISIONAL SCIENTIFIC PROGRAMME

THURSDAY 2 July 2015

09.00-10.30

Didactic session 1: Joint Session organised by the EVF and Deep Venous Reconstructive Club (DVRC)

(10 minute presentations followed by 5 min discussion)

Chair: O Maleti (Italy), Russian Chairman
09.00 From Vedensky spiral to modern concepts.
  • Evgeny Shaydakov (Russia)
09.15 History of deep venous reconstructive surgery and the DVRS-Club.
  • Oscar Maleti (Italy)
09.30 Relief of obstruction and abolition of reflux.
  • Marzia Lugli (Italy)
09.45 Ideal vein stent: Present reservations and future perspectives.
  • Athanasios Giannoukas (Greece)
10.00 Post-thrombotic syndrome after iliofemoral DVT: can it be prevented.
  • Anthony Comerota (USA)
10.15 Prescription of elastic compression in patients with iliac DVD.
  • Michel Perrin (France)
10.30 Refreshments and visit Exhibition
11.00-12.30

Didactic Session 2: From Early Venous Symptoms to Surgery: an Update

(Industry sponsored symposium)

Chairmen: Evgeny Shaydakov (Russia), Andrew Nicolaides (Cyprus)
11.00 Introduction.
  • Evgeny Shaydakov (Russia)
11.05 Better understanding of chronic venous disease (CVD).
  • Nicos Labropoulos (USA)
11.25 Surgical procedures: clinical implications.
  • Marzia Lugli (Italy)
11.45 Treatment of CVD from Cos to surgery: new evidence with Daflon.
  • Armando Mansilha (Portugal)
12.05

Panel discussion.

Moderator: Andrew Nicolaides (Cyprus)

12.25

Closing remarks.

Andrew Nicolaides (Cyprus)

12.30 Lunch and visit Exhibition
13.30-15.00

Didactic Session 3: Joint session Organised by the St Petersburg Venous Forum and Russian Society of Phlebology

(6 10 min presentations followed by 5 min discussion)

Chair:
13.30 Radiofrequency ablation (RFA) as a part of multimodality treatment in patients with congenital vascular malformations.
  • SV Sapelkin,
  • VN Dan, IE Timina,
  • NV Tarbaeva,
  • SN Krupochkin,
  • AS Karabaev,
  • TA Erkenov.
Moscow (Russia)
13.45 Control of anticoagulation for predication and personalised treatment using thrombodynamics assay.
  • I Serebriyskiy,
  • A Krylov,
  • A Shulutko,
  • F Ataullakhanov.
Moscow (Russia)
14.00 Technical aspects of the blood reflux elimination on the vena femoralis in case of the varicose of lower extremities
  • OA Alukhanyan,
  • EV Shaydakov,
  • DS Aristov,
  • Kh G Martirosyan.
Krasnodar, St Petersburg (Russia)
14.15 Laboratory support of new oral anticoagulants in present and future.
  • T Vavilova,
  • O Beliavskaia,
  • A Bekoeva,
  • E Vasilieva,
  • V Yudina.
St Petersburg (Russia)
14.30 Association of primary chronic venous disease with the incidence of deep venous thrombosis.
  • ME Shaydakov,
  • F Lurie,
  • AJ Comerota
  • A.J. Jobst
Vascular Institute, Toledo, OH (USA)
14.45 To be announced
15.00-15.30 Refreshments and visit Exhibition
15.30-16.30

Abstract Session 1: Epidemiology and Quality of Life (QOL)

(10 minute presentations, 10 minute discussion)

Chair: M Perrin (France), Russian Chairman
15.30 1.1 The influence of age on chronic venous disease. An epidemiological survey in Belgium and Luxembourg.
  • F Matthys,
  • M Vuylsteke,
  • R Colman,
  • S Thomis,
  • G Guillaume,
  • E Degrande,
  • I Staelens.
Sint-Andries ziekenhuis, Vascular Surgery, Tielt, Belgium
15.50 1.2 Quality of life after varicose vein treatment in England: A multilevel model of 24,460 patient reported outcome measures
  • J El-Sheikha.
Hull York Medical School, University of Hull, Hull Royal Infirmary, Hull, UK
Submitted in consideration for the EVF Prize
16.10 1.3 Patient reported outcome measures (PROMs) in varicose veins interventions
  • S Onida,
  • J Shalhoub,
  • HM Moore,
  • KS Head,
  • TRA Lane,
  • AH Davies.
Imperial College London, London, UK
Submitted in consideration for the EVF Prize
16.30-18.30

Abstract Session 2: RCT and Novel Therapies

(10 minute presentations, 10 minute discussion)

Chair: B Eklof (Sweden), Russian Chairmen
16.30 2.1 Use of cyanoacrylate adhesive for treatment of incompetent great saphenous veins: 12 month results of the VeClose trial
  • N Morrison1,
  • K Gibson2 on behalf of the VeClose investigators.
1Morrison Vein Institute, Scottsdale, AZ, USA and
2Overlake Medical Center, Bellevue, WA, USA
16.50 2.2 Six month clinical outcomes of a randomised controlled trial comparing mechanochemical ablation to radiofrequency ablation: the Multicentre Venefit versus ClariVein for varicose veins (VVCVV) trial
  • R Bootun1,
  • TRA Lane1,
  • B Dharmarajah1,
  • CS Lim1,2,
  • M Najem2,
  • S Renton2,
  • K Sritharan1 and
  • AH Davies1.
1Academic Section of Vascular Surgery, Imperial College London, London, UK.
2Department of Vascular Surgery, North West London Hospitals NHS Trust, Harrow, UK
Submitted in consideration for the EVF Prize
17.10 2.3 Clinical and technical five year outcomes of a randomised clinical trial comparing EVLA vs surgery for varicose veins
  • J El-Sheikha,
  • S Nandhra,
  • D Carradice,
  • T Wallace,
  • N Samuel,
  • I Chetter.
Hull York Medical School / Hull University, Academic Vascular Surgery Unit, Hull RoyalInfirmary, Hull, UK
Submitted in consideration for the EVF Prize
17.30 2.4 Influence of aspirin in patients with chronic venous insufficiency and ulcer associated
  • C Vaquero,
  • L del Rio,
  • J Antonio,
  • Gonzalez-Fajardo,
  • E San Norberto,
  • N Cenizo,
  • JA Brizuela.
Division Vascular Surgery. University Hospital of Valladolid. Spain
17.50 2.5 MPFF and sclerotherapy: friends or opponents?
  • VY Bogachev,
  • AN Kuznetsov,
  • OV Golovanova,
  • PV Yershov.
Russian National Research Medical University, Moscow, Russia
18.10 2.6 Thermal analysis of vein radiofrequency ablation ex vivo
  • YM Stoyko1,
  • MN Yashkin1,
  • CV Masayshvili1,
  • AV Tsyplyashchuk1,
  • SE Kharitonova1,
  • SS Akimov1,
  • NY Ignatieva2,
  • OL Zakharkina3.
1Pirogov National Medical and Surgical Center, Moscow, Russia
2M.V. Lomonosov Moscow State University, Moscow, Russia
Submitted in consideration for the EVF Prize
18.30 Welcome Reception (Exhibition Area)

FRIDAY 3 July 2015

08.00-10.00

Abstract Session 3. Miscellaneous

(10 minute presentations, 10 minute discussion)

Chair: A Giannoukas (Greece), Russian
08.00 3.1 Multi-sequence non-contrast MRI can predict the lysability of experimental venous thrombi and could be used to help plan deep venous reconstruction in man
  • P Saha,
  • A Phikaridou,
  • M Andia,
  • A Patel,
  • S Grover,
  • A Bajwa,
  • S Black,
  • B Modarai,
  • R Botnar,
  • A Smith.
Academic Department of Vascular Surgery, Cardiovascular Division & Division of Imaging Science, BHF Centre of Excellence, King’s College London and NIHR Biomedical Research Centre at Guy’s & St Thomas’ NHS Foundation Trust, London, UK
Submitted in consideration for the EVF Prize
08.20 3.2 Neutralisation of bleeding induced by non-vitamin K oral anticoagulants by prothrombin complex concentrates alone and in combination with antifibrinolytic agents
  • E Kalodiki1,2,
  • W Jeske1,
  • V Escalante1,
  • B McGeehan1,
  • JM Walenga1,
  • R Wahi1,
  • J Fareed1,
  • M Bakhos1.
1Ealing Hospital and Imperial College, London UK and
2Departments of Pathology and Pharmacology, Loyola University Health Systems, Maywood, IL, USA
08.40 3.3 The novel venous drainage index is impaired in patients with the post thrombotic syndrome
  • CR Lattimer,
  • E Kalodiki,
  • M Azzam,
  • V Ibegbuna,
  • A Nicolaides,
  • G Geroulakos.
Josef Pflug Vascular Laboratory, Ealing Hospital & Imperial College, London, UK
Submitted in consideration for the EVF Prize
09.00 3.4 Quantification of microcirculatory and inflammatory parameters in the evaluation of chronic venous disorders: regulation with MPFF
  • CEV Magalhaes,
  • BS Barros,
  • MR Mayall,
  • MC de Souza,
  • E Bouskela.
State University, Rio de Janeiro, Brazil
09.20 3.5 Compliance with conservative treatment in symptomatic patients with chronic venous disorders: first results from the Vein Act Program in Russia
  • DE Lishov1,
  • AI Kirienko2,
  • AA Larionov1,
  • AI Chernookov3.
1Center of Phlebology,
2N.I. Pirogov’s Russian National Research Medical University,
3I.M. Sechenov First Moscow State Medical University, Moscow, Russia
09.40 3.6 Adjustable Velcro compression devices are more effective than inelastic bandages to reduce venous oedema: A randomised, controlled pilot study
  • G Mosti1,
  • A Cavezzi2,
  • H Partsch3.
1Angiology department, Clinica MD Barbantini, Lucca, Italy.
2EuroCenter VenaLinfa, S. Benedetto del Tronto, Italy.
3Professor Emeritus Wien University, Wien, Austria
10.00-10.30 Refreshments and visit Exhibition
10.30-13.00

Presentations of Prize Winning Papers.

(10 minute presentations followed by 5 minute discussion)

Chair:
American Venous Forum
10.30 Equivalent outcomes between ultrasound-assisted thrombolysis and standard catheter directed thrombolysis for the treatment of cute pulmonary embolism.
  • NL Liang,
  • ED Avgerinos,
  • LK Marone,
  • MJ Singh,
  • MS Makaroun,
  • RA Chaer.
Univeristy of Pittsburg Medical Centre, Pittsburg, PA, USA
10.45 Prospective long term comparison of anticoagulation treatment versus thrombolysis in patients with acute iliofemoral thrombosis.
  • G Spentzouris1,
  • N Labropoulos1,
  • P Foegh2,
  • A Gasparis1,
  • A Tassiopoulos1,
  • N Baekgaard2.
1Stony Brook University Hospital, Stony Brook NY, USA.
2Vascular Clinic, Gentofte Hospital and Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Japanese Society of Phlebology
11.00 Changing surgical procedures for Budd-Chiari syndrome (a single centre experience of 66 cases).
  • H Inafuki,
  • S Higa,
  • Y Totsuka,
  • M Ando,
  • R Arakaki,
  • T Maeda,
  • Y Kise,
  • T Nagano,
  • S Yamashiro,
  • Y Kuniyoshi.
Department of Cardiovascular Surgery, Department of Cardiovascular Surgery, Division Department of Bioregulatory medicine, University of Ryukyus, Ryukyus, Japan
11.15 Indocyanine green lymphography and lymphaticovenous anastomosis for generalised lymphatic dysplasia with pleural effusion and ascites in neonates.
  • M Mihara
Department of Vascular Surgery, Saiseikai Kawaguchi General Hospital, Saitama, Japan
13.00-14.00 Lunch
14.00-14.30

EVF Key Note Lecture: Call for excellence in the management of venous disease - role of the European Venous Forum.

  • Bo Eklof (Sweden)
14.30-14.45 Microcirculatory dysfunction in chronic venous disease.
  • Eliete Bouskela (Brazil)
14.45-15.30 Tribute to Asterios Katsamouris (Past- President, 2005).
  • A Giannoukas (Greece)
15.30-16.00

Annual General Meeting (EVF Members only)

16.00-16.30 Refreshments and visit Exhibition
17.00 Depart for Boat Excursion, Visit Peterhof Palace and Gala Dinner

SATURDAY 4 July 2015

08.00-09.00

Didactic Session 4: Venous Markers and their Clinical Use

(Industry sponsored Symposium)

(10 min presentations followed by 5 min discussion)

08.00 Biomarkers of venous thromboembolism.
  • Thomas Wakefield (USA)
08.15 Biomarkers of chronic venous disease.
  • F Mannello (Italy)
08.30 MMP12 and VEGF as genetic risk factors for varicose veins.
  • AI Shevela (Russia)
08.45 Commentary and practical applications.
  • Jawed Fareed (USA)
09.00-11.00

Abstract Session 4. Venous Thromboembolism

(10 minute presentations followed by 5 minute discussion)

Chair: A Nicolaides (Cyprus), Russian
09.00 4.1 Association of primary chronic venous disease with the incidence of deep vein thrombosis
  • ME Shaydakov,
  • AJ Comerota,
  • F Lurie.
Jobst Vascular Institute, ProMedica Toledo Hospital, OH, USA
09.20 4.2 Neuromuscular electrical stimulation (NMES) for prevention of venous thromboembolism (VTE)
  • R Ravikumar1,
  • KJ Williams1,
  • A Babber1,
  • TR Lane1,
  • M Moore1,
  • J Shalhoub1,
  • AH Davies1
1Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, UK
Submitted in consideration for the EVF Prize
09.40 4.3 Mean platelet volume as a predictor of venous thromboembolism: A systematic review and meta-analysis
  • C Wilasrusmee1,
  • B Siribumrungwong2,
  • S Horsirimanont1,
  • N Proprom1,
  • A Thakkinstian3
1Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand,
2Department of Surgery, Faculty of Medicine, Thammasat University Hospital, Thammasat University, Pathumthani, Thailand.
3Section for Clinical Epidemiology and Biostatistics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
10.00 4.4 Blood hypercoagulation assessed with a thrombodynamics test predicts postoperative venous thrombosis in high risk patients
  • K Lobastov,
  • G Dementieva,
  • N Soshitova,
  • V Barinov,
  • L Laberko,
  • G Rodoman,
  • V Boyarintsev.
The Pirogov’s Russian National Research Medical University, Moscow, Russia
10.20 4.5 Incidence of hospital associated thrombosis (HAT) over a two year period in a venous thromboembolism (VTE) exemplar centre
  • T Ghatwary,
  • H Teague,
  • A Brice,
  • C Humphreys,
  • S Dimitri.
Vascular Surgery Unit and VTE Exemplar Centre, Countess of Chester NHS Foundation Trust, Chester, UK
Submitted in consideration for the EVF Prize
10.40 4.6 Drug interactions of new oral anticoagulants dibigatran, rivaroxaban and apixaban with routinely used non-anticoagulant/anti-platelet drugs
  • S Sayani1,
  • E Kalodiki1,2,
  • O Iqbal1,
  • D Hoppensteadt1,
  • J Fareed1.
1Departments of Pathology and Pharmacology, Loyola University Health Systems, Maywood, IL
2Ealing Hosptial and Imperial College, London, UK
11.00 Tea and visit Exhibiton
11.30-12.15

Didactic Session 5. “Hot” Topics

10 min presentations followed by 5 min discussion)

(Industry sponsored symposium)

11.30 Current status of graduated elastic and intermittent pneumatic compression stocking in the prevention of DVT.
  • Joseph Caprini (USA)
11.45 New data from the use of cyanoacrylate adhesive in GSV closure.
  • Thomas Proebstle (Germany)
12.00 Algorithm for management of axillary vein thrombosis.
  • George Geroulakos (UK)
12.15-13.15

Abstract Session 5: Heritability, Robotic Surgery and AVM

(10 min presentations followed by 10 min discussion)

Chair: G Mosti (Italy), A Shevela (Russia)
12.15 5.1 Assessment of the heritability of chronic venous disease
  • A Fiebig1,2,
  • P Krusche3,
  • A Wolf4,
  • M Krawczak2,4,
  • B Timm2,
  • S Nikolaus1,
  • N Frings3,
  • S Schreiber1,
1Institute for Clinical Molecular Biology, Christian-Albrechts-University, Kiel, Germany
2Biobank ‘popgen’, Section Epidemiology, Institute for Experimental Medicine, Christian-Albrechts-University, Kiel, Germany
3Capio Mosel-Eifel-Clinic, Bad Bertrich, Germany 4Institute of Medical Informatics and Statistics, Christian-Albrechts-University, Kiel, Germany
12.35 5.2 Robotic Inferior Vena Caval Surgery
  • SR Money,
  • VJ Davila,
  • R Fowl,
  • W Stone,
  • E Castle.
Mayo Clinic, Arizona, USA.
12.55 5.3 The basic approaches in the treatment of diffuse congenital vascular malformations with the presence of arteriovenous microfistulas
  • LM Chernukha,
  • OV Kashyrova,
  • AO Guch,
  • GG Vlaykov,
  • IV Altman,
  • VA Kondratuk.
National Institute of Surgery and Transplantology n. a. O.O. Shalymov under NAMS of Ukraine, Kiev, Ukraine
13.15 Lunch
14.15-16.15

Abstract Session 6: Guidelines, Stenting, Valvulooplasty, Embolisation and Venous Drainage

(10 min presentations followed by 10 min discussion)

Chair: Russian Chairman
14.15 6.1 The impact of new national guidelines on the management of lower limb venous disease in Birmingham, UK
  • H Davies,
  • M Popplewell,
  • K Darvall,
  • G Bate,
  • L Kelly,
  • A Bradbury.
University of Birmingham Department of Vascular Surgery, Heart of England NHS Foundation Trust, Birmingham, UK
Submitted in consideration for the EVF Prize
14.35 6.2 Follow up results of iliofemoral vein stenting in patients with post thrombotic syndrome
  • M Kurtoglu,
  • M Aksoy,
  • F Yanar,
  • I Azamat.
Department of General Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
14.55 6.3 One-year outcomes following deep venous reconstruction for thrombotic disease using dedicated endovenous stents
  • P Saha,
  • N Karunanithy,
  • K Breen,
  • A Patel,
  • B Hunt,
  • B Modarai,
  • S Black.
Academic Department of Vascular Surgery, Cardiovascular Division & Department of Thrombosis and Haemostasis, BHF Centre of Excellence, King’s College London and NIHR Biomedical Research Centre at Guy’s & St Thomas’ NHS Foundation Trust, London, UK
Submitted in consideration for the EVF Prize
15.15 6.4 A new modality in vein treatment: Extraluminal valvuloplasty by interventional injection of hyaluronic acid gel
  • JC Ragg
Angioclinic Vein Centers, Interventional Phleblogy, Berlin, Germany
15.35 6.5 Pelvic pain syndrome: Venographic manifestation of ovariocele involvement and endovascular correction of venous congestion
  • V Ryzhkov,
  • A Karev,
  • S Verezgova,
  • S Melnik.
Central Regional Clinical Hospital, North-West Medical University, St-Petersburg, Russia
15.55 6.6 Increasing thigh compression pressure correlates with a reduction in the venous drainage index of air plethysmography
  • CR Lattimer,
  • S Doucet,
  • E Kalodiki,
  • M Azzam,
  • V Ibegbuna,
  • G Geroulakos.
Josef Pflug Vascular Laboratory, Ealing Hospital & Imperial College, London, UK
Submitted in consideration for the EVF Prize
16.15 End of meeting and Presentation of EVF Prizes